Doctor profile · Federal record
Dr. KARAN BHALLA, MD
Cardiovascular Disease Physician (CMS: CARDIOVASCULAR DISEASE (CARDIOLOGY)) · Interventional Cardiology Physician · PASADENA, TX
- NPI 1407902794
- Accepts Medicare
- MIPS 87.6 / 100 · 2023
- 28 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
5413 CRENSHAW RD, 400
PASADENA, TX 775056407
(713) 943-2800
fax (713) 943-2801
Credentials & registration
- NPI registered
- January 2007 — 19 yrs on file
- Profile last updated
- October 31, 2022
- Year of graduation
- 1998 — 28 yrs since
- Specialty taxonomy
- 207RC0000X — NUCC code
- State license (1)
- Texas #M3160
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1407902794. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
12,284
Distinct HCPCS
10
Medicare allowed
$2,670,877
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J2785 |
Injection, regadenoson, 0.1 mg | 1,962 | 505 | $55 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 1,645 | 585 | $131 | |
G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 1,043 | 150 | $38 | |
93298 |
Evaluation of cardiac rhythm monitor system, remote up to 30 days | 837 | 111 | $27 | |
93000 |
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 651 | 491 | $15 | |
93306 |
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 568 | 500 | $182 | |
93015 |
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 546 | 542 | $68 | |
A9555 |
Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 513 | 472 | $359 | |
78431 |
Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 474 | 472 | $2,454 | |
78434 |
Nuclear medicine study of heart muscle blood flow by pet | 372 | 371 | $185 |
In context: peer comparison
Among 5 peers in this city , average services per provider: 162. This provider delivers 76× the peer median.Open Payments
Industry payments received
All-time total
$8,396
Transactions
63
Manufacturers
11
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Boston Scientific Corporation | 27 | $7,456.56 | |
| Novartis Pharmaceuticals Corporation | 14 | $291.33 | |
| Medtronic, Inc. | 6 | $206.87 | |
| AstraZeneca Pharmaceuticals LP | 2 | $120.70 | |
| Biosense Webster, Inc. | 3 | $109.99 | |
| SANOFI-AVENTIS U.S. LLC | 3 | $65.46 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $49.09 | |
| Kiniksa Pharmaceuticals International, plc | 3 | $47.18 | |
| Itamar Medical Inc | 1 | $19.07 | |
| Novo Nordisk Inc | 1 | $16.84 | |
| Amgen Inc. | 1 | $13.25 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
4,753
Patients
1,736
Total drug cost
$1,093,092
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Metoprolol Succinate | Generic | 744 | 251 | $14,053 |
| Atorvastatin Calcium | Generic | 733 | 266 | $9,783 |
| Clopidogrel (Clopidogrel Bisulfate) | Brand | 553 | 215 | $9,782 |
| Amlodipine Besylate | Generic | 533 | 212 | $4,308 |
| Eliquis (Apixaban) | Brand | 395 | 116 | $433,252 |
| Xarelto (Rivaroxaban) | Brand | 274 | 93 | $361,246 |
| Furosemide | Generic | 226 | 90 | $1,598 |
| Entresto (Sacubitril/Valsartan) | Brand | 204 | 61 | $239,115 |
| Metoprolol Tartrate | Generic | 203 | 78 | $1,923 |
| Losartan Potassium | Generic | 197 | 68 | $2,426 |